4//SEC Filing
Muralidhar Bali 4
Accession 0001209191-22-030549
CIK 0001698530other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:50 PM ET
Size
6.2 KB
Accession
0001209191-22-030549
Insider Transaction Report
Form 4
EXICURE, INC.XCUR
Muralidhar Bali
Director
Transactions
- Purchase
Common Stock
2022-05-19$0.19/sh+1,472,126$285,151→ 8,449,126 total(indirect: See footnotes)
Footnotes (2)
- [F1]The shares are held by Abingworth Bioventures VII LP ("Abingworth VII"). Abingworth Bioventures VII GP LP serves as the general partner of Abingworth VII. Abingworth General Partner VII LLP, (together with Abingworth Bioventures VII GP LP, the "General Partners"), serves as the general partner of Abingworth Bioventures VII GP LP. Abingworth VII (acting by its general partner Abingworth Bioventures VII GP LP, acting by its general partner Abingworth General Partner VII LLP) has delegated to Abingworth LLP all investment and dispositive power over the securities held by Abingworth VII. The Reporting Person, a Director of the Issuer, is a member of an investment committee of Abingworth VII which approves investment and voting decisions by majority vote and no individual member has the sole control or voting power over the securities held by Abingworth VII.
- [F2]Each of Abingworth VII, Abingworth LLP, the General Partners, the Reporting Person and each member of the investment committee disclaims beneficial ownership of the common stock held by Abingworth VII, except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
EXICURE, INC.
CIK 0001698530
Entity typeother
Related Parties
1- filerCIK 0001784138
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:50 PM ET
- Size
- 6.2 KB